Sugar and Stroke: Cerebrovascular Disease and Blood Glucose Control.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e31, doi. 10.1111/j.1755-5922.2010.00166.x
- By:
- Publication type:
- Article
Works matching IS 17555914 AND DT 2011 AND VI 29 AND IP 6
Results: 16
1
2
Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e100, doi. 10.1111/j.1755-5922.2010.00202.x
- By:
- Publication type:
- Article
3
There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e67, doi. 10.1111/j.1755-5922.2010.00190.x
- By:
- Publication type:
- Article
4
Coronary Artery Calcium Scoring in Cardiovascular Risk Assessment.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e43, doi. 10.1111/j.1755-5922.2010.00172.x
- By:
- Publication type:
- Article
5
Local Drug Delivery for Treatment of Coronary and Peripheral Artery Disease.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e54, doi. 10.1111/j.1755-5922.2010.00187.x
- By:
- Publication type:
- Article
6
Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 404, doi. 10.1111/j.1755-5922.2010.00169.x
- By:
- Publication type:
- Article
7
Cholesteryl Ester Transfer Protein Inhibition in Cardiovascular Risk Management: Ongoing Trials will End the Confusion.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e89, doi. 10.1111/j.1755-5922.2010.00201.x
- By:
- Publication type:
- Article
8
The Quest for New Anticoagulants: From Clinical Development to Clinical Practice.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e12, doi. 10.1111/j.1755-5922.2010.00160.x
- By:
- Publication type:
- Article
9
Therapeutic Angiogenesis for the Management of Refractory Angina: Current Concepts.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e1, doi. 10.1111/j.1755-5922.2010.00153.x
- By:
- Publication type:
- Article
10
Therapeutic Strategies in Patients with Chronic Stable Coronary Artery Disease.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e23, doi. 10.1111/j.1755-5922.2010.00164.x
- By:
- Publication type:
- Article
11
Alternatives to Warfarin-The Next Generation of Anticoagulants.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. e80, doi. 10.1111/j.1755-5922.2010.00197.x
- By:
- Publication type:
- Article
12
Ascorbic Acid Infusion Blunts CD40L Upregulation in Patients Undergoing Coronary Stent.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 385, doi. 10.1111/j.1755-5922.2010.00168.x
- By:
- Publication type:
- Article
13
PPAR-γ Agonism for Cardiovascular and Renal Protection.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 377, doi. 10.1111/j.1755-5922.2010.00222.x
- By:
- Publication type:
- Article
14
Cardiac Natriuretic Peptides: From Basic Discovery to Clinical Practice.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 362, doi. 10.1111/j.1755-5922.2010.00152.x
- By:
- Publication type:
- Article
15
Prognosis of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafts for Ostial Right Coronary Lesions in Propensity-Matched Individuals.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 395, doi. 10.1111/j.1755-5922.2010.00219.x
- By:
- Publication type:
- Article
16
Vascular PAR-1: Activity and Antagonism.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 349, doi. 10.1111/j.1755-5922.2010.00140.x
- By:
- Publication type:
- Article